Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06805500

Robotic Assisted Balance and Exoskeleton Training (REACTION) in Neurorehabilitation: a Feasibility Study

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Roessingh Research and Development · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to explore the effect on walking speed of a new robotic assisted balance and gait trainer (REACTION) and their subsystems in individuals with neurological disorders. The study will provide insight in the feasibility of REACTION. Participants will: * Participate in two sessions in which every session contains a walking task and balance tasks * end the study with a semi-structured interview

Detailed description

The first day will be focusing on 4 conditions: tasks without aid, tasks with regular aid, task with the ABLE Regain and tasks with REACTION. The first and third condition consist of a walking task and balance tasks, The second and fourth condition is only focusing on the walking task with the aim of getting familiar to the device and the walking task. The second day will also be focusing on four conditions: tasks without aid, tasks with aid, tasks with the GABLE Core and task with REACTION (Fig 3.2). The conditions 'tasks without aid', 'tasks with the GABLE Core' and 'tasks with REACTION' consist of a walking task and balance tasks (similar to day 1). The condition 'tasks with aid' only consists of a walking task. A semi-structured interview with the corresponding physiotherapist and patient will be held to gather more information about usability and feasibility of REACTION from a therapist's and patient's perspective.

Conditions

Interventions

TypeNameDescription
DEVICEREACTIONCombination of a exoskeleton and gait trainer
DEVICEABLE RegainExoskeleton
DEVICEGABLE CoreGait trainer

Timeline

Start date
2025-04-01
Primary completion
2026-01-01
Completion
2026-01-01
First posted
2025-02-03
Last updated
2025-02-12

Locations

2 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06805500. Inclusion in this directory is not an endorsement.